{"id":"https://openalex.org/W7225394652","doi":"https://doi.org/10.5281/zenodo.24008506","title":"The Prevalence and Risk Factors of Carbapenem-Resistant Acinetobacter Species in Catheterized and Non-Catheterized Patients in A Tertiary Hospital at Nnewi, Anambra State, Nigeria","display_name":"The Prevalence and Risk Factors of Carbapenem-Resistant Acinetobacter Species in Catheterized and Non-Catheterized Patients in A Tertiary Hospital at Nnewi, Anambra State, Nigeria","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225394652","doi":"https://doi.org/10.5281/zenodo.24008506"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24008506","doi":"https://doi.org/10.5281/zenodo.24008506","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24008506","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24008506","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161014440","display_name":"Ezeoye Kenneth Uchechukwu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ezeoye Kenneth Uchechukwu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161060302","display_name":"Akaeme Favour Amarachi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akaeme Favour Amarachi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acinetobacter","display_name":"Acinetobacter","score":0.8579999804496765},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":1.0},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.7020000219345093},{"id":"https://openalex.org/keywords/indwelling-urinary-catheter","display_name":"indwelling urinary catheter","score":0.7369999885559082},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7919999957084656},{"id":"https://openalex.org/keywords/meropenem-resistance","display_name":"meropenem resistance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/antimicrobial-susceptibility","display_name":"antimicrobial susceptibility","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.7900000214576721},{"id":"https://openalex.org/keywords/infection-control","display_name":"infection control","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8285999894142151},{"id":"https://openalex.org/C2777821550","wikidata":"https://www.wikidata.org/wiki/Q411552","display_name":"Doripenem","level":5,"score":0.8105000257492065},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.7562000155448914},{"id":"https://openalex.org/C2778523567","wikidata":"https://www.wikidata.org/wiki/Q310457","display_name":"Acinetobacter","level":3,"score":0.7348999977111816},{"id":"https://openalex.org/C2778368673","wikidata":"https://www.wikidata.org/wiki/Q553220","display_name":"Ertapenem","level":5,"score":0.7181000113487244},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5307999849319458},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.5099999904632568},{"id":"https://openalex.org/C2776685102","wikidata":"https://www.wikidata.org/wiki/Q410897","display_name":"Carbapenem","level":3,"score":0.4374000132083893},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43230000138282776},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.38830000162124634},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.3228999972343445},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.31279999017715454},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.31040000915527344},{"id":"https://openalex.org/C186079640","wikidata":"https://www.wikidata.org/wiki/Q719602","display_name":"Prevalence","level":3,"score":0.30889999866485596},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.30469998717308044},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.3019999861717224},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.2904999852180481},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.27959999442100525},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.27469998598098755},{"id":"https://openalex.org/C3017595490","wikidata":"https://www.wikidata.org/wiki/Q17006263","display_name":"University hospital","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.25929999351501465},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.25839999318122864}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24008506","doi":"https://doi.org/10.5281/zenodo.24008506","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24008506","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.24008507","doi":"https://doi.org/10.5281/zenodo.24008507","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24008507","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24008506","doi":"https://doi.org/10.5281/zenodo.24008506","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24008506","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2923196122","https://openalex.org/W7133203130","https://openalex.org/W4411965647","https://openalex.org/W3001831358","https://openalex.org/W7223720004","https://openalex.org/W7204862845","https://openalex.org/W4403376643","https://openalex.org/W2481292432","https://openalex.org/W4382457287","https://openalex.org/W2017779504"],"abstract_inverted_index":{"A":[0],"study":[1,33,166],"was":[2,34,77],"conducted":[3],"to":[4,39,186],"determine":[5],"the":[6,80,87,100,106,113,121],"prevalence":[7,89,109],"and":[8,17,27,42,49,60,73,133,143,147,151,179,190],"risk":[9],"factors":[10],"of":[11,90],"carbapenem-resistant":[12,169],"Acinetobacter":[13,170,195],"spp.":[14,171],"among":[15,94],"catheterized":[16,48],"non-catheterized":[18,51],"patients":[19],"at":[20],"Nnamdi":[21],"Azikiwe":[22],"University":[23],"Teaching":[24],"Hospital,":[25],"Nnewi,":[26],"Anambra":[28],"State,":[29],"Nigeria.":[30,204],"The":[31,84,126,165,182],"cross-sectional":[32],"carried":[35],"out":[36],"from":[37],"May":[38],"July":[40],"2025":[41],"included":[43],"200":[44],"hospitalized":[45],"participants:":[46],"82":[47],"118":[50],"patients.":[52],"Questionnaire":[53],"data":[54],"were":[55,63,71,138,158],"collected":[56,64],"through":[57],"oral":[58],"interviews,":[59],"urine":[61],"specimens":[62],"in":[65],"sterile":[66],"containers.":[67],"Conventional":[68],"culture":[69],"methods":[70],"used,":[72],"antimicrobial":[74,180,191,200],"susceptibility":[75,192],"testing":[76],"performed":[78],"using":[79],"Kirby\u2013Bauer":[81],"disc-diffusion":[82],"method.":[83],"report":[85],"recorded":[86],"highest":[88,114,128],"significant":[91,156],"bacterial":[92],"growth":[93],"participants":[95],"aged":[96],"56\u201365":[97],"years":[98,104],"(38.2%);":[99],"age":[101,144],"group":[102],"36\u201345":[103,146],"had":[105,120],"lowest":[107,122],"reported":[108,115,123,127,139,159],"(15.8%).":[110],"Doripenem":[111],"showed":[112],"resistance":[116,124],"(95.5%),":[117],"while":[118],"ertapenem":[119],"(51.3%).":[125],"multidrug-resistance":[129],"pattern":[130],"involved":[131],"doripenem":[132],"meropenem":[134],"(86.8%).":[135],"Statistical":[136],"associations":[137,157],"between":[140],"positive":[141],"isolates":[142],"groups":[145],"46\u201355":[148],"years,":[149],"occupation,":[150],"catheterization":[152],"status.":[153],"No":[154],"statistically":[155],"for":[160,175],"symptoms":[161],"or":[162],"medical":[163],"history.":[164],"concluded":[167],"that":[168],"represented":[172],"a":[173],"concern":[174],"hospital":[176],"infection":[177],"prevention":[178],"treatment.":[181],"findings":[183],"support":[184],"attention":[185],"hygiene,":[187],"infection-control":[188],"practices,":[189],"testing.":[193],"Keywords:":[194],"spp.;":[196],"carbapenem":[197],"resistance;":[198],"catheterization;":[199],"susceptibility;":[201],"urinary":[202],"isolates;":[203]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}